Table I.
Group | D0 | Dq | N | SF2 | SER |
---|---|---|---|---|---|
TLR9 siRNA + IR | 2.38 | 4.39 | 2.85 | 0.82 | 1.03 |
Control + IR | 2.46 | 4.56 | 2.86 | 0.84 | – |
Control siRNA + IR | 2.42 | 4.40 | 2.82 | 0.82 | 1.02 |
TLR9 siRNA + CpG ODN + IR | 2.41 | 4.40 | 2.82 | 0.81 | 1.01 |
Control + CpG ODN + IR | 1.92 | 2.90 | 2.52 | 0.67 | 1.28 |
Control siRNA + CpG ODN + IR | 1.91 | 3.00 | 2.57 | 0.68 | 1.29 |
A549 cells treated with CpG ODN 7909 plus IR exhibited lower values of D0, Dq, N and SF2 compared with those treated with IR alone, and the SER was 1.28. No significant difference between the D0, Dq, N and SF2 values in the TLR9 siRNA-transfected A549 cells treated with CpG ODN 7909 plus IR compared with those treated with IR alone was observed, and the SER was 1.01. Compared with those of TLR9 siRNA-transfected A549 cells, the D0, Dq, N and SF2 values of control siRNA transfection cells demonstrated no significant difference. D0, slope rate of survival curve; Dq, initial shoulder of survival curve; N, extrapolation value of D0, which is an associated parameter reflecting primary radiation sensitivity of cells; SF2, the survival fraction after 2 Gy irradiation; TLR9, toll-like receptor 9; CpG ODN, cytosine-phosphorothioate-guanine-containing oligodeoxynucleotides; IR, irradiation; SER, sensitivity enhancement ratio; si, small interfering.